Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Other
This study is for people with early breast cancer that:
have large amounts of a protein called human epidermal growth factor receptor (HER2 positive)
don’t have receptors for the hormone oestrogen (oestrogen receptor negative or ER negative)
It is for people who are going to have a cancer drug treatment before surgery.
Recruitment start: 22 May 2019
Recruitment end: 31 December 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Daniel Rea
Cancer Research UK
University of Birmingham
Roche
This is Cancer Research UK trial number: CRUKE/16/025.
Last reviewed: 22 January 2025
CRUK internal database number: 15302
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
